Literature DB >> 22814563

[Undesired cutaneous adverse drug reactions: What is new?].

R Treudler1, J C Simon.   

Abstract

New therapeutic agents, i.e., biologicals, may induce a variety of novel cutaneous adverse reactions (CAR), which hardly can be assigned to existing classification systems. Basing on clinical examples, we present a recently established classification system for CAR to novel drugs. In addition, management strategies for CAR to tumor necrosis factor-α antagonists and to epidermal growth factor receptor inhibitors are discussed.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22814563     DOI： 10.1007/s00108-012-3057-y

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


  29 in total

Review 1.  Managing premedications and the risk for reactions to infusional monoclonal antibody therapy.

Authors:  Christine H Chung
Journal:  Oncologist       Date:  2008-06

Review 2.  New drug therapies and their effect on the skin.

Authors:  Regina Treudler
Journal:  J Dtsch Dermatol Ges       Date:  2009-07       Impact factor: 5.584

Review 3.  Dermatological side effects of hepatitis C and its treatment: patient management in the era of direct-acting antivirals.

Authors:  Patrice Cacoub; Marc Bourlière; Jann Lübbe; Nicolas Dupin; Peter Buggisch; Geoffrey Dusheiko; Christophe Hézode; Odile Picard; Ramon Pujol; Siegfried Segaert; Bing Thio; Jean-Claude Roujeau
Journal:  J Hepatol       Date:  2011-08-30       Impact factor: 25.083

Review 4.  Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis.

Authors:  Angelique N Collamer; Daniel F Battafarano
Journal:  Semin Arthritis Rheum       Date:  2010-06-26       Impact factor: 5.532

5.  Symptom profile and risk factors of anaphylaxis in Central Europe.

Authors:  M Worm; G Edenharter; F Ruëff; K Scherer; C Pföhler; V Mahler; R Treudler; R Lang; K Nemat; A Koehli; B Niggemann; S Hompes
Journal:  Allergy       Date:  2012-02-16       Impact factor: 13.146

6.  Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists.

Authors:  H-H Lee; I-H Song; M Friedrich; A Gauliard; J Detert; J Röwert; H Audring; S Kary; G-R Burmester; W Sterry; M Worm
Journal:  Br J Dermatol       Date:  2007-03       Impact factor: 9.302

7.  Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions.

Authors:  A Vultaggio; A Matucci; F Nencini; S Pratesi; P Parronchi; O Rossi; S Romagnani; E Maggi
Journal:  Allergy       Date:  2009-11-27       Impact factor: 13.146

Review 8.  Drug-induced lupus erythematosus.

Authors:  Camilla Dalle Vedove; Micol Del Giglio; Donatella Schena; Giampiero Girolomoni
Journal:  Arch Dermatol Res       Date:  2008-09-17       Impact factor: 3.017

9.  Cutaneous events during treatment of chronic inflammatory joint disorders with anti-tumour necrosis factor alpha: a cross-sectional study.

Authors:  A C Davaine; A Saraux; S Prigent; I Kupfer-Bessaguet; D Roswag; P Plantin; P Schoenlaub; F Talarmin; A Zagnoli; L Misery
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-08-18       Impact factor: 6.166

10.  Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Sandra Muñoz; Natalia Soria; Diana Galiana; Laura Bertolaccini; Maria-Jose Cuadrado; Munther A Khamashta
Journal:  Medicine (Baltimore)       Date:  2007-07       Impact factor: 1.889
View more
  2 in total

Review 1.  [Adverse drug reactions in elderly people : First data from the Leipzig Research Center for Civilization Diseases (LIFE)].

Authors:  R Treudler; F Walther; P Ahnert; J-C Simon
Journal:  Hautarzt       Date:  2017-01       Impact factor: 0.751

Review 2.  [Drug-induced pruritus].

Authors:  K Maleki; E Weisshaar
Journal:  Hautarzt       Date:  2014-05       Impact factor: 0.751
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.